2749 |
Balloon Expandable System |
Alan C. Yeung |
Apr. 21. 16 |
2748 |
Does Carotid Stent Cell Design Matter?: Open vs. Closed vs. Micromesh |
Mark W. Burket |
Apr. 21. 16 |
2747 |
TAVR for Bicuspid AS |
Raj Makkar |
Apr. 21. 16 |
2746 |
Tailored Carotid Protection: Matching the Device to the Patient |
Jae-Hwan Lee |
Apr. 21. 16 |
2745 |
Selection of Device and Size: Based on MDCT Assessment |
Sung Han Yoon |
Apr. 21. 16 |
2744 |
Turn to Starting Line - Which Strategy for Whom?: CAS vs. CEA vs. Medical Therapy |
Robert Bersin |
Apr. 21. 16 |
2743 |
Predictor and Prevention of Vascular Complications |
Michael Kang-Yin Lee |
Apr. 21. 16 |
2742 |
A Novel Sirolimus Drug Coated Balloon Technology |
Robert Bersin |
Apr. 21. 16 |
2741 |
BRS Failure: Insights from Imagings |
Yoshinobu Onuma |
Apr. 21. 16 |
2740 |
Stent Thrombosis Risk After BRS |
Davide Capodanno |
Apr. 21. 16 |